Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2011 | 09-2010 | 09-2009 | 12-2008 | 09-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 72 | 3 | N/A | N/A | 974 |
| Other current assets | 0 | 0 | 0 | 1 | 0 |
| TOTAL | $102 | $33 | $1 | $1 | $1,000 |
| Non-Current Assets | |||||
| PPE Net | 60 | 42 | 67 | N/A | 76 |
| Intangibles | 208 | 219 | 450 | 0 | 426 |
| Other Non-Current Assets | 0 | 219 | 0 | 450 | 0 |
| TOTAL | $268 | $480 | $517 | $450 | $502 |
| Total Assets | $369 | $294 | $518 | $451 | $1,502 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 405 | 398 | 1,576 | 0 | 1,586 |
| Accrued Expenses | 246 | 72 | 76 | N/A | 12 |
| Other current liabilities | N/A | N/A | N/A | 340 | N/A |
| TOTAL | $1,833 | $3,288 | $2,529 | $340 | $2,742 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,833 | $3,288 | $2,529 | $340 | $2,742 |
| Shareholders' Equity | |||||
| Common Shares | 14 | 33 | 33 | N/A | 32 |
| Retained earnings | -28,774 | -25,765 | -22,689 | N/A | -14,909 |
| TOTAL | $-1,464 | $-2,994 | $-2,011 | $N/A | $-1,240 |
| Total Liabilities And Equity | $369 | $294 | $518 | $340 | $1,502 |